Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kate Butler is active.

Publication


Featured researches published by Kate Butler.


Breast Cancer Research and Treatment | 1998

Multidisciplinary weight management in locoregional breast cancer: results of a phase II study.

Pamela J. Goodwin; Mary Jane Esplen; Kate Butler; Janis Winocur; Kathleen I. Pritchard; Sandy Brazel; Joe Gao; Andrea Miller

Sixty-one women with newly diagnosed locoregional breast cancer (T 1–3, N0-1, M0) having an initial Body Mass Index (BMI) between 20 and 35 kg/m2 who were receiving standard adjuvant treatment (chemotherapy, tamoxifen, and/or radiation) were asked to avoid weight gain (if initial BMI ≤ 25 kg/m2) or to lose up to 10 kg (if initial BMI 25–35 kg/m2) over one year. Women participated in twenty group sessions (10 weekly, 10 monthly) which involved a psychological supportive-expressive group intervention supplemented by individual weight goals, and nutrition and exercise programs. Fifty-five non-censored women (5 developed recurrence, 1 died of a subarachnoid hemorrhage) lost a mean of 0.53 ± 3.72 kg. Weight loss was greatest in initially overweight women (BMI ≥ 25 kg/m2) who lost 1.63 ± 4.11 kg (p = 0.01 compared to normal weight women) and in those not receiving chemotherapy who lost 2.15 ± 2.83 kg (p=0.0004 compared to those receiving chemotherapy). 70.9% met predefined criteria for success. Aerobic exercise increased significantly during the intervention (p = 0.00005) and was the strongest predictor of success (OR 1.73 for each additional 30 minutes of exercise weekly, p=0.003). Changes in caloric intake were not significant, but fat intake decreased and carbohydrate and fibre intake increased significantly during the intervention. Eating behavior and psychological status improved significantly. Thus, this multidisciplinary weight management intervention successfully prevented weight gain in women with newly diagnosed locoregional breast cancer, and helped overweight women lose weight.


Clinical Genetics | 2007

Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.

Mary Jane Esplen; Lisa Madlensky; Melyssa Aronson; H Rothenmund; Steve Gallinger; Kate Butler; B Toner; Jiahui Wong; M Manno; John R. McLaughlin

Hereditary non‐polyposis colorectal cancer (HNPCC) represents about 1–3% of all cases of colorectal cancer (CRC). The objectives of the study were to examine motivational factors, expectations and psychosocial functioning in a sample of CRC survivors undergoing genetic testing for HNPCC. A cross‐sectional survey of 314 colorectal cancer patients recruited through a population‐based colon cancer family registry was conducted. Motivations for genetic testing for hereditary cancer were similar to those of clinic‐based samples of CRC patients and included learning of the increased risk to offspring and finding out if additional screening was needed. While age at diagnosis and sex were associated with psychological functioning, significant predictors of post‐counseling distress were perceived lower satisfaction with social support, an escape‐avoidant coping style and the anticipation of becoming depressed if a mutation was present. Most cancer survivors anticipated disclosing test results to relatives and physicians. Cancer survivors reported several motivations for genetic testing for HNPCC that varied by sex. A subgroup of survivors with lower satisfaction with social support and an escape‐avoidant coping style were worried about the potential impact of genetic test results and demonstrated more distress following counseling. Findings have implications for future research and potential support needs during the genetic counseling and testing process.


Psycho-oncology | 2009

The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers.

Mary Jane Esplen; Noreen Stuckless; Jonathan J. Hunter; Alexander Liede; Kelly Metcalfe; Gordon Glendon; Steven A. Narod; Kate Butler; Jenna Scott; Ellen Irwin

Genetic testing for BRCA1/2 has psychosocial impacts including those related to views of personal health, sense of self and identity and body image. The centrality of a persons self‐concept in maintaining physical and psychosocial well‐being has been well recognized; however, to date research exploring altered self‐concept related to carrier knowledge is limited.


Cancer | 2004

A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations

Mary Jane Esplen; Jon Hunter; Molyn Leszcz; Ellen Warner; Steven A. Narod; Kelly Metcalfe; Gord Glendon; Kate Butler; Alexander Liede; Mary Anne Young; Stephanie Kieffer; Lisa DiProspero; Ellen Irwin; Jiahui Wong

Women with a BRCA1/BRCA2 mutation experience significant challenges. These include decision‐making regarding surgical options and notification to offspring and family, along with a sense of isolation, which may lead to psychological and emotional distress. The current study developed, standardized, and conducted preliminary testing of a supportive‐expressive group therapy intervention designed to address these challenges.


American Journal of Medical Genetics Part A | 2004

An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers

Jordana Segal; Mary Jane Esplen; Brenda B. Toner; Sylvia Baedorf; Steven A. Narod; Kate Butler

Disclosure of the results of a positive genetic mutation to offspring can be challenging. The purpose of this study was to investigate the content and process of disclosure from BRCA1/2 carriers to their offspring. A semi‐structured questionnaire focused on the disclosure processes between parent and offspring. Thirty‐one/40 mothers with BRCA1/2 mutations completed the cross‐sectional survey. Sixteen carriers (51.6%) chose to disclose their results to all of their children, thirteen carriers (41.9%) chose not to disclose their results, and two carriers (6.5%) chose to disclose to some of their children. The age of a child appeared to be the most significant contributing factor in the decision to disclose. The mean age of the offspring who learned of the positive test result was 24.3 years with most carriers advocating the ideal age range for disclosure from 19 to 25 years. There was a discrepancy between actual and potential disclosure topics between those who had disclosed and those who had not disclosed at the time of the survey. Women who disclosed their result tended to do so alone, within a week of learning their own results, equally to male and female offspring and expressed that the relationships between themselves and their children had strengthened since revealing the presence of a genetic mutation in the family. Women who had not disclosed the results of their genetic test to offspring were significantly more interested in receiving additional individual counseling, educational videos, and email newsletters that focus on disclosure of this complex and life altering information compared to those who had already disclosed. Disclosure of BRCA1/2 results is determined primarily by age of offspring, is usually done by women alone, relatively soon after receiving results and appears to enhance the relationships between mothers and offspring. Both disclosed and non‐disclosed carriers demonstrated significant interest in a variety of interventions to support the disclosure process.


Psycho-oncology | 2000

A supportive-expressive group intervention for women with a family history of breast cancer: results of a phase II study.

Mary Jane Esplen; Brenda B. Toner; Jonathan J. Hunter; Gordon Glendon; Alexander Liede; Steve Narod; Noreen Stuckless; Kate Butler; Barb Field

Background: Evidence suggests that there are significant psychological and behavioural sequelae associated with having a family history of breast cancer (BC) which can interfere with comprehension of risk estimates.


Plastic and Reconstructive Surgery | 2016

A Comparison of Psychological Response, Body Image, Sexuality, and Quality of Life between Immediate and Delayed Autologous Tissue Breast Reconstruction: A Prospective Long-term Outcome Study

Toni Zhong; Jiayi Hu; Shaghayegh Bagher; Anthony Vo; Anne C. OʼNeill; Kate Butler; Christine B. Novak; Stefan O.P. Hofer; Kelly Metcalfe

Background: This is the first study to use generic distress, cancer-specific, and procedure-specific measures to prospectively evaluate psychological responses, body image, sexuality, and health-related quality of life in immediate compared with delayed breast reconstruction. Methods: Consecutive patients undergoing autologous immediate and delayed breast reconstruction (June of 2009 to December of 2010) completed the Hospital Anxiety and Depression Scale, Body Image Scale, Sexuality Scale, and BREAST-Q preoperatively and postoperatively (6, 12, and 18 months). Linear mixed-effects analyses between each outcome and time point were performed. Results: One hundred six women underwent mastectomy with immediate (n = 30) and delayed breast reconstruction (n = 76). Before reconstruction, 26 percent of patients had abnormal anxiety scores and 9 percent had abnormal depression scores, with no significant differences between groups. Patients awaiting delayed breast reconstruction had significantly impaired prereconstruction body image (p = 0.01) and sexuality (p = 0.01) and worse satisfaction with breast (p < 0.01), psychological (p < 0.01), and sexual well-being (p < 0.01). At 18 months after immediate and delayed breast reconstruction, there was significant improvement in anxiety, depression, body image, sexuality, and health-related quality of life. Conclusions: This single-center study shows that mastectomy with immediate breast reconstruction may protect breast cancer patients from a period of psychosocial distress, poor body image, and diminished sexual well-being compared with those waiting for delayed breast reconstruction. In patients who are oncologically eligible and strongly interested in breast reconstruction, efforts should be made to provide immediate breast reconstruction to decrease the interval of psychosocial distress, poor body image, and impaired sexuality.


Psycho-oncology | 2008

The phases of disclosing BRCA1/2 genetic information to offspring

Susan Clarke; Kate Butler; Mary Jane Esplen

Objective: Women who carry a genetic mutation for hereditary breast/ovarian cancer (BRCA1 or BRCA2) are at high risk to develop cancer. A positive genetic test result also has implications for a BRCA1/2 carriers offspring who each have a 50% chance of inheriting the mutation. The dissemination of BRCA1/2‐related information by carriers to offspring is not well understood. Our study examines the experiences of BRCA1/2 carriers in communicating genetic information to their offspring using a grounded theory approach.


Clinical Genetics | 2011

Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome

Mary Jane Esplen; N Stuckless; Steve Gallinger; Melyssa Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; Jane Green; Kate Butler; Hv Petersen; Jiahui Wong

Esplen MJ, Stuckless N, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV, Wong J. Development and validation of an instrument to measure the impact of genetic testing on self‐concept in Lynch syndrome.


Journal of Surgical Oncology | 2013

The influence of dispositional optimism on decision regret to undergo major breast reconstructive surgery

Toni Zhong; Shaghayegh Bagher; Kunaal Jindal; Delong Zeng; Anne C. O'Neill; Sheina A. Macadam; Kate Butler; Stefan O.P. Hofer; Andrea L. Pusic; Kelly Metcalfe

It is not known if optimism influences regret following major reconstructive breast surgery. We examined the relationship between dispositional optimism, major complications and decision regret in patients undergoing microsurgical breast reconstruction.

Collaboration


Dive into the Kate Butler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toni Zhong

University Health Network

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge